Skip to Content

CL7 1.5 mg (Rivastigmine Tartrate 1.5 mg)

Pill with imprint CL7 1.5 mg is Yellow, Capsule-shape and has been identified as Rivastigmine Tartrate 1.5 mg. It is supplied by Macleods Pharmaceuticals Limited.

Rivastigmine is used in the treatment of alzheimer's disease; lewy body dementia; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CL7 1.5 mg

Rivastigmine Tartrate

Imprint:
CL7 1.5 mg
Strength:
1.5 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Cholinesterase inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Macleods Pharmaceuticals Limited
National Drug Code (NDC):
33342-0089

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide